WebDisclosure WebDisclosure
Basculer en Français
11249 Companies
249887 Keywords
178199 Articles
135750 Press releases
Headlines Articles Press releases OBI Pharma USA, Inc. Remove
  1. Home
  2. Companies
  3. OBI Pharma USA, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/15/2026 at 10:45, 6 months 16 days ago

    OBI Pharma Presents Ten New Poster Sessions at AACR 2026

    Cancer Treatment ADC Technology OBI Pharma Tumor Heterogeneity GlycOBI® Platform
  • BRIEF

    published on 04/15/2026 at 10:45, 6 months 16 days ago

    OBI Pharma présente dix nouvelles sessions d'affiches à l'AACR 2026

    Traitement Du Cancer Technologie ADC OBI Pharma Hétérogénéité Tumorale Plateforme GlycOBI®
  • PRESS RELEASE

    published on 04/15/2026 at 10:40, 6 months 16 days ago

    OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies

    OBI Pharma showcases advancements in ADC technology at AACR 2026, highlighting GlycOBI platform. Poster presentations feature OBI-902, OBI-904, OBI-201, OBI-221, and novel Obrion technology
    Poster Presentations ADC Technology AACR 2026 OBI Pharma GlycOBI Platform
    Logo of OBI Pharma USA, Inc.
Accesswire
  • Published on 10/30/2026 at 23:35, 15 hours 30 minutes ago

    Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement

  • Published on 10/30/2026 at 23:30, 15 hours 35 minutes ago

    Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario

  • Published on 10/30/2026 at 20:47, 18 hours 18 minutes ago

    CoTec Holdings Corp. Comments on Share Trading

  • Published on 10/30/2026 at 19:00, 20 hours 5 minutes ago

    Electric Royalties Ltd. Announces Application for Warrant Extension

  • Published on 10/30/2026 at 15:30, 23 hours 35 minutes ago

    Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE
EQS Group
  • Published on 10/30/2026 at 22:49, 16 hours 16 minutes ago

    EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE

  • Published on 10/30/2026 at 22:30, 16 hours 34 minutes ago

    /C O R R E C T I O N - OCI Global/

  • Published on 10/30/2026 at 20:17, 18 hours 47 minutes ago

    2CRSi SA: Résultats annuels 2025-2026

  • Published on 10/30/2026 at 20:17, 18 hours 47 minutes ago

    2CRSi SA: 2025-2026 annual results

  • Published on 10/30/2026 at 18:38, 20 hours 27 minutes ago

    EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report

View all EQS
Les Echos
  • Published on 10/30/2026 at 23:00, 16 hours 5 minutes ago

    BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY

  • Published on 10/30/2026 at 23:00, 16 hours 5 minutes ago

    Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie

  • Published on 10/30/2026 at 20:42, 18 hours 22 minutes ago

    TINC en PMV investeren in Storm Group (B)

  • Published on 10/30/2026 at 20:42, 18 hours 22 minutes ago

    TINC and PMV invest in Storm Group (B)

  • Published on 10/30/2026 at 20:42, 18 hours 22 minutes ago

    TINC and PMV invest in Storm Group (B)

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy